Carcinogenesis Advance Access published online on December 20, 2006
Carcinogenesis, doi:10.1093/carcin/bgl250
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Functional Polymorphisms in FAS and FASL Contribute to Increased Apoptosis of Tumor Infiltration Lymphocytes and Risk of Breast Cancer
1 Center of Breast Diseases and Department of Abdominal Surgery, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
3 Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
4 Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
* To whom correspondence should be addressed. Fax: +86 1067722460; E-mail: dlin{at}public.bta.net.cn
The FAS-FASL system plays crucial role in counterattack of cancer cell against immune system. This study examined the effects of FAS (–1377G/A and –670A/G) and FASL (–844T/C and 7896G/C) polymorphisms on breast cancer risk and apoptosis of T lymphocytes. The effect on breast cancer risk was determined by case-control analysis of 840 patients and 840 controls. The effects on T lymphocyte apoptosis were determined by activation-induced cell death (AICD) of T cells ex vivo and by analysing apoptotic tumor-infiltrating lymphocytes (TILs) in breast cancer tissue. We found moderately increased risk associated with FAS –1377AG (OR, 1.29; 95% CI, 1.05–1.59) and –1377AA (OR, 1.36; 95% CI, 1.01–1.82) genotypes compared with the –1377GG genotype and decreased risk associated with FASL –844CT (OR, 0.76; 95% CI, 0.62–0.94) and –844TT (OR, 0.66; 95% CI, 0.43–1.00) genotypes compared with the –844CC genotype. T lymphocytes with the FASL –844CC genotype had heightened FASL expression, which is associated with increased AICD of the T cells stimulated by MCF-7 cells or phytohemagglutinin compared with the FASL –844TT genotype (10.38 ± 4.09 and 24.29 ± 1.50 versus 6.03 ± 0.41 and 17.96 ± 3.66; P < 0.05 and 0.001). Breast cancer patients with the FASL –844CC genotype had higher apoptotic TILs in their cancer tissues than those with the FASL –844TT genotype (33.7% ± 1.2% versus 19.1% ± 2.0%; P = 0.007). These findings indicate functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Key Words: FAS • FASL • polymorphisms • breast cancer • activation-induced cell death
B. Zhang and T. Sun contributed equally to this work.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. D. Meacham, J. W. Antoon, M. E. Burow, A. P. Struckhoff, and B. S. Beckman Sphingolipids as Determinants of Apoptosis and Chemoresistance in the MCF-7 Cell Model System Experimental Biology and Medicine, November 1, 2009; 234(11): 1253 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhang, H. Xue, W. Gong, M. Wang, L. Yuan, S. Han, and Z. Zhang FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies Carcinogenesis, March 1, 2009; 30(3): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Park, W.-K. Lee, D.-K. Jung, J.-E. Choi, T.-I. Park, E.-B. Lee, S. Cho, J.-Y. Park, S.-I. Cha, C.-H. Kim, et al. Polymorphisms in the FAS and FASL Genes and Survival of Early Stage Non-small Cell Lung Cancer Clin. Cancer Res., March 1, 2009; 15(5): 1794 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ter-Minassian, R. Zhai, K. Asomaning, L. Su, W. Zhou, G. Liu, R. S. Heist, T. J. Lynch, J. C. Wain, X. Lin, et al. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer Carcinogenesis, November 1, 2008; 29(11): 2147 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yang, T. Sun, L. Wang, D. Yu, X. Zhang, X. Miao, J. Liu, D. Zhao, H. Li, W. Tan, et al. Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer Clin. Cancer Res., May 15, 2008; 14(10): 3230 - 3236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, M. Agrawal, S. M. Eng, S. K. Sagiv, S. L. Teitelbaum, A. I. Neugut, and R. M. Santella Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk Carcinogenesis, December 1, 2007; 28(12): 2548 - 2551. [Abstract] [Full Text] [PDF]
|
|